HBK INVESTMENTS L P - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HBK INVESTMENTS L P ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$7,849,000
-29.3%
7,000,000
-30.0%
0.03%
-19.5%
Q4 2021$11,106,000
-6.1%
10,000,0000.0%0.04%
-10.9%
Q3 2021$11,822,000
+0.3%
10,000,0000.0%0.05%
+12.2%
Q2 2021$11,791,000
+6.2%
10,000,0000.0%0.04%
-19.6%
Q1 2021$11,104,000
-0.9%
10,000,0000.0%0.05%
-30.1%
Q4 2020$11,202,000
+13.8%
10,000,0000.0%0.07%0.0%
Q3 2020$9,840,00010,000,0000.07%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Wellesley Asset Management 30,477,080$31,017,7581.54%
SHENKMAN CAPITAL MANAGEMENT INC 17,691,000$17,931,7261.34%
BRAIDWELL LP 37,509,000$37,250,1881.18%
III Capital Management 16,200,000$16,068,4830.81%
DLD Asset Management, LP 7,500,000$7,471,8750.80%
TENOR CAPITAL MANAGEMENT Co., L.P. 34,375,000$34,057,6740.73%
Worth Venture Partners, LLC 1,034,000$1,029,4760.61%
CAPSTONE INVESTMENT ADVISORS, LLC 40,200,000$39,922,6200.18%
BOOTHBAY FUND MANAGEMENT, LLC 3,055,000$3,041,6340.07%
Leucadia National 7,149,000$7,051,5720.06%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders